Sponsor

Duke Clinical Research Institute

United States 2400 Pratt Street, 27705-3976, United States

About the sponsor

The sponsor’s clinical research activity is centred on juvenile idiopathic arthritis, with a focus on children affected by polyarticular course juvenile idiopathic arthritis and persistent inflammatory joint disease.

Juvenile idiopathic arthritis
Polyarticular course juvenile idiopathic arthritis
Childhood inflammatory arthritis

Its research interest includes treatment strategies for paediatric patients whose disease remains active after prior TNF inhibitor therapy.

About Specializations

Duke Clinical Research Institute runs clinical trials in conditions such as Juvenile idiopathic arthritis, among others.

Juvenile idiopathic arthritis

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Juvenile idiopathic arthritis

Recruiting

Registered drugNo placebo

Study of abatacept, tocilizumab, and tofacitinib compared to a second TNF inhibitor for children with juvenile idiopathic arthritis who did not respond to TNF inhibitor treatment

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Abatacept
Sponsor:Duke Clinical Research Institute

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →